4.7 Article

Magnetic resonance imaging identifies early effects of sunitinib treatment in human melanoma xenografts

Journal

Publisher

BMC
DOI: 10.1186/1756-9966-32-93

Keywords

Sunitinib; Antiangiogenic treatment; Hypoxia; DW; MRI; DCE-MRI

Categories

Funding

  1. Norwegian Cancer Society
  2. South-Eastern Norway Regional Health Authority

Ask authors/readers for more resources

Background: Antiangiogenic treatment may change the tumor microenvironment and hence influence the effect of conventional therapies. The potential of diffusion weighted magnetic resonance imaging (DW-MRI) and dynamic contrast enhanced MRI (DCE-MRI) in assessing microenvironmental effects of sunitinib treatment was investigated in this preclinical study. Methods: Sunitinib-treated and untreated A-07 tumors were subjected to DW-MRI and DCE-MRI, and parametric images of ADC and K-trans were produced. Microvascular density, hypoxic fraction, and necrotic fraction were assessed from immunohistochemical preparations, and tumor interstitial fluid pressure (IFP) was assessed with probe measurement. Results: Sunitinib-treated tumors showed reduced microvascular density, increased hypoxic fraction, increased necrotic fraction, increased ADC, and reduced K-trans, but did not differ from untreated tumors in growth rate and IFP. Conclusions: Sunitinib treatment affected the tumor microenvironment without affecting tumor size. DW-MRI and DCE-MRI were sensitive to the sunitinib-induced changes in the tumor microenvironment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available